Table 7.
Factors associated with confirmed malaria fever incidence in the PACOME participants Multivariate Poisson regression*
|
Variable |
Outcome |
|||
|---|---|---|---|---|
| |
Confirmed malaria (N = 410) |
Confirmed or suspected malaria (N = 413) |
||
| Relative risk | 95% CI | Relative risk | 95% CI | |
| Age (for 5 years) |
1.25 |
(0.70-2.27) |
1.27 |
(0.74-2.18) |
| CD4 (for 50 cells/mm3) |
0.83 |
(0.71-0.99) |
0.82 |
(0.71-0.96) |
| Type of anti-malarial chemoprophylaxis (cotrimoxazole alone vs mefloquine IPTp +/− cotrimoxazole) |
1.72 |
(0.61-4.89) |
2.24 |
(0.83-6.07) |
| Antiretroviral therapy started before inclusion |
0.39 |
(0.12-1.21) |
0.34 |
(0.12-0.98) |
| Symptomatic malaria during the early pregnancy (before inclusion) |
8.89 |
(2.68-29.52) |
7.1 |
(2.35-21.49) |
| Primiparity |
1.09 |
(0.21-5.58) |
0.84 |
(0.17-4.16) |
| Delivery during the rainy season | 0.55 | (0.20-1.54) | 0.63 | (0.25-1.60) |
*adjusted on the health centre.